PAVmed (PAVM) Competitors $0.63 +0.00 (+0.05%) Closing price 04:00 PM EasternExtended Trading$0.64 +0.01 (+1.71%) As of 06:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock PAVM vs. SPAI, APYX, MODD, TELA, COCH, BDMD, DXR, POCI, ECOR, and MDAIShould you be buying PAVmed stock or one of its competitors? The main competitors of PAVmed include Safe Pro Group Inc. Common Stock (SPAI), Apyx Medical (APYX), Modular Medical (MODD), TELA Bio (TELA), Envoy Medical (COCH), Baird Medical Investment (BDMD), Daxor (DXR), Precision Optics (POCI), electroCore (ECOR), and Spectral AI (MDAI). These companies are all part of the "medical equipment" industry. PAVmed vs. Safe Pro Group Inc. Common Stock Apyx Medical Modular Medical TELA Bio Envoy Medical Baird Medical Investment Daxor Precision Optics electroCore Spectral AI Safe Pro Group Inc. Common Stock (NASDAQ:SPAI) and PAVmed (NASDAQ:PAVM) are both small-cap business services companies, but which is the superior stock? We will compare the two companies based on the strength of their media sentiment, profitability, valuation, risk, analyst recommendations, earnings, community ranking, dividends and institutional ownership. Which has better valuation & earnings, SPAI or PAVM? Safe Pro Group Inc. Common Stock has higher earnings, but lower revenue than PAVmed. Safe Pro Group Inc. Common Stock is trading at a lower price-to-earnings ratio than PAVmed, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSafe Pro Group Inc. Common Stock$2.17M20.28-$12.29M-$0.81-3.58PAVmed$3.00M3.60-$64.18M$0.710.89 Do institutionals and insiders believe in SPAI or PAVM? 19.9% of PAVmed shares are owned by institutional investors. 54.8% of Safe Pro Group Inc. Common Stock shares are owned by insiders. Comparatively, 7.3% of PAVmed shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Does the media prefer SPAI or PAVM? In the previous week, PAVmed had 4 more articles in the media than Safe Pro Group Inc. Common Stock. MarketBeat recorded 6 mentions for PAVmed and 2 mentions for Safe Pro Group Inc. Common Stock. Safe Pro Group Inc. Common Stock's average media sentiment score of 0.82 beat PAVmed's score of 0.71 indicating that Safe Pro Group Inc. Common Stock is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Safe Pro Group Inc. Common Stock 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive PAVmed 2 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is SPAI or PAVM more profitable? PAVmed has a net margin of 602.97% compared to Safe Pro Group Inc. Common Stock's net margin of 0.00%. Company Net Margins Return on Equity Return on Assets Safe Pro Group Inc. Common StockN/A N/A N/A PAVmed 602.97%N/A -92.36% Does the MarketBeat Community favor SPAI or PAVM? PAVmed received 204 more outperform votes than Safe Pro Group Inc. Common Stock when rated by MarketBeat users. CompanyUnderperformOutperformSafe Pro Group Inc. Common StockN/AN/APAVmedOutperform Votes20466.23% Underperform Votes10433.77% Do analysts recommend SPAI or PAVM? PAVmed has a consensus target price of $19.50, indicating a potential upside of 2,994.26%. Given PAVmed's stronger consensus rating and higher possible upside, analysts plainly believe PAVmed is more favorable than Safe Pro Group Inc. Common Stock.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Safe Pro Group Inc. Common Stock 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00PAVmed 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummaryPAVmed beats Safe Pro Group Inc. Common Stock on 10 of the 15 factors compared between the two stocks. Get PAVmed News Delivered to You Automatically Sign up to receive the latest news and ratings for PAVM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PAVM vs. The Competition Export to ExcelMetricPAVmedSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$10.77M$4.47B$5.35B$8.38BDividend YieldN/A43.64%5.22%4.10%P/E Ratio-0.1429.4326.8419.71Price / Sales3.6067.72391.39116.98Price / CashN/A51.0838.2534.62Price / Book-0.196.236.794.50Net Income-$64.18M$68.16M$3.23B$248.18M7 Day Performance-13.68%18.33%4.07%1.14%1 Month Performance-3.80%23.04%12.52%15.20%1 Year Performance-65.75%20.61%16.83%6.56% PAVmed Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PAVMPAVmed4.1253 of 5 stars$0.63+0.0%$19.50+2,994.3%-65.6%$10.77M$3.00M-0.1490SPAISafe Pro Group Inc. Common StockN/A$2.97+1.2%N/AN/A$45M$2.17M0.0011Earnings ReportGap DownAPYXApyx Medical0.7704 of 5 stars$1.11-4.7%N/A-6.9%$41.76M$48.10M-1.33270MODDModular Medical0.8682 of 5 stars$1.02+2.0%N/A-48.1%$41.48MN/A-1.9220TELATELA Bio1.8961 of 5 stars$1.01-6.5%$7.25+617.8%-78.8%$39.95M$69.30M-0.60120COCHEnvoy Medical1.7404 of 5 stars$1.67-1.5%$9.13+448.0%-46.9%$35.51M$212,000.00-1.2134BDMDBaird Medical InvestmentN/A$5.35+3.3%N/AN/A$35.22M$33.05M0.00N/ADXRDaxor3.8148 of 5 stars$7.26-6.3%$25.00+244.4%-21.5%$35.12M$2.13M0.0037POCIPrecision Optics0.6709 of 5 stars$4.58-1.1%N/A-32.6%$35.11M$18.68M-7.1680Earnings ReportGap DownHigh Trading VolumeECORelectroCore2.8968 of 5 stars$4.82+3.7%$25.50+429.0%-24.0%$34.67M$25.18M-2.6350Positive NewsGap DownHigh Trading VolumeMDAISpectral AI2.9187 of 5 stars$1.36+9.7%$4.75+249.3%-26.1%$34.43M$29.58M-2.0983Analyst Revision Related Companies and Tools Related Companies Safe Pro Group Inc. Common Stock Competitors Apyx Medical Competitors Modular Medical Competitors TELA Bio Competitors Envoy Medical Competitors Baird Medical Investment Competitors Daxor Competitors Precision Optics Competitors electroCore Competitors Spectral AI Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PAVM) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PAVmed Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PAVmed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy PAVM Stock Free PAVM Stock Alerts